Biallelic PAN2 variants in individuals with a syndromic neurodevelopmental disorder and multiple congenital anomalies.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
05 2022
Historique:
received: 17 09 2021
accepted: 17 02 2022
revised: 10 01 2022
pubmed: 20 3 2022
medline: 14 5 2022
entrez: 19 3 2022
Statut: ppublish

Résumé

PAN2 encodes a subunit of a deadenylation complex with important functions in mRNA stability and post-transcriptional regulation of gene expression. A homozygous frameshift deletion in PAN2 was reported in a single affected individual with developmental delay and multiple congenital anomalies. Here, we describe five additional individuals from three unrelated families with homozygous predicted loss-of-function variants in PAN2. The affected individuals presented with significant overlap in their clinical features, including mild-moderate intellectual disability, hypotonia, sensorineural hearing loss, EEG abnormalities, congenital heart defects (tetralogy of Fallot, septal defects, dilated aortic root), urinary tract malformations, ophthalmological anomalies, short stature with other skeletal anomalies, and craniofacial features including flat occiput, ptosis, long philtrum, and short neck. Our data confirm that biallelic predicted loss-of-function variants in PAN2 cause a syndrome with multiple congenital anomalies, and suggest an important role of mRNA polyA tail length for proper organ formation.

Identifiants

pubmed: 35304602
doi: 10.1038/s41431-022-01077-y
pii: 10.1038/s41431-022-01077-y
pmc: PMC9090724
doi:

Substances chimiques

RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

611-618

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© 2022. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Kaplanis J, Samocha KE, Wiel L, Zhang Z, Arvai KJ, Eberhardt RY, et al. Evidence for 28 genetic disorders discovered by combining healthcare and research data. Nature. 2020;586:757–62.
doi: 10.1038/s41586-020-2832-5
Weil D, Piton A, Lessel D, Standart N. Mutations in genes encoding regulators of mRNA decapping and translation initiation: links to intellectual disability. Biochem Soc Trans. 2020;48:1199–211.
doi: 10.1042/BST20200109
Wolf J, Valkov E, Allen MD, Meineke B, Gordiyenko Y, McLaughlin SH, et al. Structural basis for Pan3 binding to Pan2 and its function in mRNA recruitment and deadenylation. EMBO J. 2014;33:1514–26.
doi: 10.15252/embj.201488373
Brown CE, Sachs AB. Poly(A) tail length control in Saccharomyces cerevisiae occurs by message-specific deadenylation. Mol Cell Biol. 1998;18:6548–59.
doi: 10.1128/MCB.18.11.6548
Yamashita A, Chang TC, Yamashita Y, Zhu W, Zhong Z, Chen CY, et al. Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat Struct Mol Biol. 2005;12:1054–63.
doi: 10.1038/nsmb1016
Maddirevula S, Alsahli S, Alhabeeb L, Patel N, Alzahrani F, Shamseldin HE, et al. Expanding the phenome and variome of skeletal dysplasia. Genet Med. 2018;20:1609–16.
doi: 10.1038/gim.2018.50
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–30.
doi: 10.1002/humu.22844
Silversides CK, Lionel AC, Costain G, Merico D, Migita O, Liu B, et al. Rare copy number variations in adults with tetralogy of Fallot implicate novel risk gene pathways. PLoS Genet. 2012;8:e1002843.
doi: 10.1371/journal.pgen.1002843
Reuter MS, Jobling R, Chaturvedi RR, Manshaei R, Costain G, Heung T, et al. Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot. Genet Med. 2019;21:1001–7.
doi: 10.1038/s41436-018-0260-9
Manshaei R, Merico D, Reuter MS, Engchuan W, Mojarad BA, Chaturvedi R, et al. Genes and pathways implicated in tetralogy of fallot revealed by ultra-rare variant burden analysis in 231 genome sequences. Front Genet. 2020;11:957.
doi: 10.3389/fgene.2020.00957
Trost B, Walker S, Wang Z, Thiruvahindrapuram B, MacDonald JR, Sung WWL, et al. A Comprehensive workflow for read depth-based identification of copy-number variation from whole-genome sequence data. Am J Hum Genet. 2018;102:142–55.
doi: 10.1016/j.ajhg.2017.12.007
Lessel D, Ozel AB, Campbell SE, Saadi A, Arlt MF, McSweeney KM, et al. Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations. Hum Genet. 2018;137:921–39.
doi: 10.1007/s00439-018-1957-1
Lessel D, Wu D, Trujillo C, Ramezani T, Lessel I, Alwasiyah MK, et al. Dysfunction of the MDM2/p53 axis is linked to premature aging. J Clin Investig. 2017;127:3598–608.
doi: 10.1172/JCI92171
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.
doi: 10.1038/nbt.1754
Tummala H, Walne A, Collopy L, Cardoso S, de la Fuente J, Lawson S, et al. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Investig. 2015;125:2151–60.
doi: 10.1172/JCI78963
Schafer IB, Yamashita M, Schuller JM, Schussler S, Reichelt P, Strauss M, et al. Molecular basis for poly(A) RNP architecture and recognition by the Pan2-Pan3 deadenylase. Cell. 2019;177:1619–31 e21.
doi: 10.1016/j.cell.2019.04.013
Wiederhold K, Passmore LA. Cytoplasmic deadenylation: regulation of mRNA fate. Biochem Soc Trans. 2010;38:1531–6.
doi: 10.1042/BST0381531
Tucker M, Valencia-Sanchez MA, Staples RR, Chen J, Denis CL, Parker R. The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell. 2001;104:377–86.
doi: 10.1016/S0092-8674(01)00225-2
Mason PJ, Bessler M. mRNA deadenylation and telomere disease. J Clin Investig. 2015;125:1796–8.
doi: 10.1172/JCI81506
Bennett RL, French KS, Resta RG, Doyle DL. Standardized human pedigree nomenclature: update and assessment of the recommendations of the National Society of Genetic Counselors. J Genet Couns. 2008;17:424–33.
doi: 10.1007/s10897-008-9169-9

Auteurs

Miriam S Reuter (MS)

CGEn, The Hospital for Sick Children, Toronto, ON, Canada. miriam.reuter@sickkids.ca.
The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada. miriam.reuter@sickkids.ca.
Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada. miriam.reuter@sickkids.ca.

Michael Zech (M)

Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
Institute of Human Genetics, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Janine Altmüller (J)

Cologne Center for Genomics, University of Cologne and University Hospital Cologne, Cologne, Germany.

Tracy Heung (T)

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.

Laura Pölsler (L)

Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.

René Santer (R)

Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Holger Thiele (H)

Cologne Center for Genomics, University of Cologne and University Hospital Cologne, Cologne, Germany.

Brett Trost (B)

The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada.
Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.

Christian Kubisch (C)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stephen W Scherer (SW)

The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON, Canada.
Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
McLaughlin Centre, University of Toronto, Toronto, ON, Canada.

Sabine Rudnik-Schöneborn (S)

Institute of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.

Anne S Bassett (AS)

Clinical Genetics Research Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Division of Cardiology, Toronto Congenital Cardiac Centre for Adults at the Peter Munk Cardiac Centre, Department of Medicine, University Health Network, Toronto, ON, Canada.
The Dalglish Family 22q Clinic for Adults with 22q11.2 Deletion Syndrome, Department of Psychiatry, and Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH